Involvement of multitargets in paeoniflorin-induced preconditioning

Journal of Pharmacology and Experimental Therapeutics

Volumn 319, Issue 1, 2006, Pages 165-180

  Chen, Dong Mei ^a   Xiao, Liang ^b   Cai, Xin ^a   Zeng, Rong ^a   Zhu, Xing Zu ^a,c  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b Department of Research and Development   (China)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; BIOLOGICAL MARKER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PAEONIFLORIN; PROTEIN; RGS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; CONTROLLED STUDY; ISCHEMIA; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MORTALITY; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; RAT; REPERFUSION INJURY;

ADENOSINE TRIPHOSPHATE; AMINO ACID SEQUENCE; ANIMALS; ARACHIDONIC ACID; BENZOIC ACIDS; BRAIN-DERIVED NEUROTROPHIC FACTOR; BRIDGED COMPOUNDS; GLUCOSIDES; HSP70 HEAT-SHOCK PROTEINS; ISCHEMIC PRECONDITIONING; MALE; MAP KINASE SIGNALING SYSTEM; MOLECULAR SEQUENCE DATA; NALOXONE; NEUROPROTECTIVE AGENTS; NF-KAPPA B; POTASSIUM CHANNELS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A1; RGS PROTEINS;

EID: 33749024778     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.104380     Document Type: Article

References (37)

1. 1A-receptor agonist, Bay x 3702. Brain Res 858:121-128.
2. Andrus PK, Fleck TJ, Oostveen JA, and Hall ED (1997) Neuroprotective effects of the novel brain-penetrating pyrrolopyrimidine antioxidants U-101033E and U-104067F against post-ischemic degeneration of nigrostriatal neurons. J Neurosci Res 47:650-654.
3. Borlongan CV, Sumaya IC, and Moss DE (2005) Methanesulfonyl fluoride, an acetylcholinesterase inhibitor, attenuates simple learning and memory deficits in ischemic rats. Brain Res 1038:50-58.
4. Bouhamdan M, Michelhaugh SK, Calin-Jageman I, Ahern-Djamali S, and Bannon MJ (2004) Brain-specific RGS9-2 is localized to the nucleus via its unique proline-rich domain. Biochim Biophys Acta 1691:141-150.
5. Buttner T, Weyers S, Postert T, Sprengelmeyer R, and Kuhn W(1997) S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction. Stroke 28:1961-1965.
6. Carboni S, Antonsson B, Gaillard P, Gotteland JP, Gillon JY, and Vitte PA (2005) Control of death receptor and mitochondrial-dependent apoptosis by c-Jun Nterminal kinase in hippocampal CA1 neurones following global transient ischaemia. J Neurochem 92:1054-1060.
7. Dewar D and Dawson DA (1997) Change of cytoskeletal protein immunostaining in myelinated fibre tracts after focal cerebral ischaemia in the rat. Acta Neuropathol (Berl) 93:71-77.
8. Dhodda VK, Sailor KA, Bowen KK, and Vemuganti R (2004) Putative endogenous mediators of preconditioning-induced ischemic tolerance in rat brain identified by genomic and proteomic analysis. J Neurochem 89:73-89.
9. Fontella FU, Cimarosti H, Crema LM, Thomazi AP, Leite MC, and Salbego C (2005) Acute and repeated restraint stress influences cellular damage in rat hippocampal slices exposed to oxygen and glucose deprivation. Brain Res Bull 65:443-450.
10. Goto H, Shimada Y, Akechi Y, Kohta K, Hattori M, and Terasawa K (1996) Endothelium-dependent vasodilator effect of extract prepared from the roots of Paeonia lactiflora on isolated rat aorta. Planta Med 62:436-439.
11. Heximer SP, Srinivasa SP, Bernstein LS, Bernard JL, Linder ME, and Hepler JR (1999) G protein selectivity is a determinant of RGS2 function. J Biol Chem 274:34253-34259.
12. Iijima T, Mishima T, Tohyama M, Akagawa K, and Iwao Y (2003) Mitochondrial membrane potential and intracellular ATP content after transient experimental ischemia in the cultured hippocampal neuron. Neurochem Int 43:263-269.
13. Inoue N, Goto S, Korematsu K, Oyama T, Yamada K, and Nagahiro S (1996) Cytochrome oxidase activity during acute focal ischaemia in rat brain. A pathophysiology of acute focal ischaemia: part 2. Acta Neurochir (Wien) 138:1126-1131.
14. Jiang W, Van Cleemput, Sheerin AH, Ji SP, Zhang Y, and Saucier DM (2005) Involvement of extracellular regulated kinase and p38 kinase in hippocampal seizure tolerance. J Neurosci Res 81:581-588.
15. Kokubo Y, Matson GB, Derugin N, Hill T, Mancuso A, and Chan PH (2002) Transgenic mice expressing human copper-zinc superoxide dismutase exhibit attenuated apparent diffusion coefficient reduction during reperfusion following focal cerebral ischemia. Brain Res 947:1-8.
16. Liu CL, Ge P, Zhang F, and Hu BR (2005a) Co-translational protein aggregation after transient cerebral ischemia. Neuroscience 134:1273-1284.
17. Liu DZ, Xie KQ, Ji XQ, Ye Y, Jiang CL, and Zhu XZ (2005b) Neuroprotective effect of paeoniflorin on cerebral ischemic rat by activating adenosine A (1) receptor in a manner different from its classical agonists. Br J Pharmacol 146:604-611.
18. Mitsumoto A, Kim KR, Oshima G, Kunimoto M, Okawa K, and Iwamatsu A (1999) Glyoxalase I is a novel nitric-oxide-responsive protein. Biochem J 344:837-844.
19. Ohtsuki T, Matsumoto M, Hayashi Y, Yamamoto K, Kitagawa K, and Ogawa S (1995) Reperfusion induces 5-lipoxygenase translocation and leukotriene C4 production in ischemic brain. Am J Physiol 268:H1249-H1257.
20. Park EM, Cho S, Frys KA, Glickstein SB, Zhou P, and Anrather J (2006) Inducible nitric oxide synthase contributes to gender differences in ischemic brain injury. J Cereb Blood Flow Metab 26:392-401.
21. Prasad KN, Cole WC, and Prasad KC (2002) Risk factors for Alzheimer's disease: role of multiple antioxidants, non-steroidal anti-inflammatory and cholinergic agents alone or in combination in prevention and treatment. J Am Coll Nutr 21:506-522.
22. Pulsinelli WA, Jacewicz M, Levy DE, Petito CK, and Plum F (1997) Ischemic brain injury and the therapeutic window. Ann N Y Acad Sci 835:187-192.
23. Ramakrishnan P, Dickson DW, and Davies P (2003) Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies. Neurobiol Dis 14:251-264.
24. Reshef A, Sperling O, and Zoref-Shani E (2000) Opening of K (ATP) channels is mandatory for acquisition of ischemic tolerance by adenosine. Neuroreport 11:463-465.
25. Ryu G, Park EK, Joo JH, Lee BH, Choi BW, and Jung DS (2001) A new antioxidant monoterpene glycoside, alpha-benzoyloxypaeoniflorin from Paeonia suffruticosa. Arch Pharm Res (NY) 24:105-108.
26. Sasaki T, Kitagawa K, Yamagata K, Takemiya T, Tanaka S, and Omura-Matsuoka E (2004) Amelioration of hippocampal neuronal damage after transient forebrain ischemia in cyclooxygenase-2-deficient mice. J Cereb Blood Flow Metab 24:107-113.
27. Sensenbrenner M, Lucas M, and Deloulme JC (1997) Expression of two neuronal markers, growth-associated protein 43 and neuron-specific enolase, in rat glial cells. J Mol Med 75:653-663.
28. Shen J, Ma S, Chan P, Lee W, Fung PC, and Cheung RT (2006) Nitric oxide down-regulates caveolin-1 expression in rat brains during focal cerebral ischemia and reperfusion injury. J Neurochem 96:1078-1089.
29. Song YS, Lee YS, and Chan PH (2005) Oxidative stress transiently decreases the IKK complex (IKKalpha, beta, and gamma), an upstream component of NF-kappaB signaling, after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 25:1301-1311.
30. Soriano MA, Justicia C, Ferrer I, Rodriguez-Farre E, and Planas AM (1997) Striatal infarction in the rat causes a transient reduction of tyrosine hydroxylase immunoreactivity in the ipsilateral substantia nigra. Neurobiol Dis 4:376-385.
31. Sydserff SG, Borelli AR, Green AR, and Cross AJ (2002) Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat: studies on dose, plasma concentration and therapeutic time window. Br J Pharmacol 135:103-112.
32. Tabata K, Matsumoto K, Murakami Y, and Watanabe H (2001) Ameliorative effects of paeoniflorin, a major constituent of peony root, on adenosine A1 receptor-mediated impairment of passive avoidance performance and long-term potentiation in the hippocampus. Biol Pharm Bull 24:496-500.
33. Takano K, Tatlisumak T, Bergmann AG, Gibson DG 3rd, and Fisher M (1997) Reproducibility and reliability of middle cerebral artery occlusion using a silicone-coated suture (Koizumi) in rats. J Neurol Sci 153:8-11.
34. Tran CTL, Leiper JM, and Vallance P (2003) The DDAH/ADMA/NOS pathway. Atheroscler Suppl 4:33-40.
35. Wakahara N, Katoh H, Yaguchi Y, Uehara A, Satoh H, and Terada H (2004) Difference in the cardioprotective mechanisms between ischemic preconditioning and pharmacological preconditioning by diazoxide in rat hearts. Circ J 68:156-162.
36. Xiao L, Wang YZ, Luo XT, Ye Y, and Zhu XZ (2005) Effects of paeoniflorin on the cerebral infarction, behavioral and cognitive impairments at the chronic stage of transient middle cerebral artery occlusion in rats. Life Sci 78:413-420.
37. Yoshida M, Nakakimura K, Cui YJ, Matsumoto M, and Sakabe T (2004) Adenosine A (1) receptor antagonist and mitochondrial ATP-sensitive potassium channel blocker attenuate the tolerance to focal cerebral ischemia in rats. J Cereb Blood Flow Metab 24:771-779.